Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation.

The integrated concentration of serum GH (IC-GH) is used for the assessment of spontaneous GH secretion. In order to use the IC-GH as a diagnostic tool a normative reference range needs to be established. We determined the IC-GH by continuous blood withdrawal in 119 children of normal height, weight and growth rate. Although the mean IC-GH increased with pubertal status, 4.4 +/- 1.2 micrograms/L at Tanner I (n = 36), 5.5 +/- 2.1 micrograms/L at Tanner II-III (n = 43), and 5.8 +/- 1.6 at Tanner IV-V (n = 40) (P less than 0.03), there was a considerable overlap of individual IC-GH levels between the pubertal groups. Gender affected the mean IC-GH level slightly, but not the range. Although the mean IC-GH of girls tended to be higher than that of boys this difference was not statistically significant. Ninety five percent of the IC-GH values were above the 3.2 micrograms/L level. The response to pharmacological stimulation (clonidine, insulin, or arginine) was also evaluated in 68 of the subjects. The peak GH response to pharmacological stimulation (micrograms/L) with clonidine 21.0 +/- 10.7 (n = 66) was significantly higher than to either arginine 13.1 +/- 6.1 (n = 23) or insulin 14.2 +/- 6.3 (n = 19) (P less than 0.01). The peak response to clonidine increased significantly with pubertal status (P less than 0.001) and there was an interactive effect of gender and pubertal stage where the GH response of prepubertal boys exceeded that of prepubertal girls but the response of pubertal girls exceeded that of pubertal boys (P less than 0.02). The peak stimulated GH levels was correlated with IC-GH in this subgroup r = 0.52, P less than 0.0001). This study provides a large normative data base for IC-GH and the GH provocative tests in normally growing children of varying pubertal status.

[1]  K. Alberti,et al.  Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. , 1990, The Journal of clinical endocrinology and metabolism.

[2]  G. Saggese,et al.  Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone. , 1989, American journal of diseases of children.

[3]  F. Kaufman,et al.  Growth hormone secretory dynamics in subjects with normal stature. , 1989, The Journal of pediatrics.

[4]  D. Donaldson,et al.  Growth hormone secretory profiles: variation on consecutive nights. , 1989, The Journal of pediatrics.

[5]  A. Hanukoglu,et al.  The effect of testosterone therapy on spontaneous growth hormone secretion in boys with constitutional delay. , 1988, American journal of diseases of children.

[6]  K. Albertsson-Wikland,et al.  Analyses of 24-hour growth hormone profiles in children: relation to growth. , 1988, The Journal of clinical endocrinology and metabolism.

[7]  F. Cassorla,et al.  The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. , 1988, The New England journal of medicine.

[8]  J. Bierich Serum Growth Hormone Levels in Provocation Tests and During Nocturnal Spontaneous Secretion: a Comparative Study 1 , 1987, Acta paediatrica Scandinavica. Supplement.

[9]  A. Rogol,et al.  Impact of intensive venous sampling on characterization of pulsatile GH release. , 1987, The American journal of physiology.

[10]  D. Shulman,et al.  Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. , 1986, The Journal of clinical endocrinology and metabolism.

[11]  R. McCARTER,et al.  The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. , 1985, The Journal of clinical endocrinology and metabolism.

[12]  W. Mendelson,et al.  Growth hormone neurosecretory dysfunction. A treatable cause of short stature. , 1984, JAMA.

[13]  R. Lanes,et al.  Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects. , 1982, The Journal of pediatrics.

[14]  W M Moore,et al.  Physical growth: National Center for Health Statistics percentiles. , 1979, The American journal of clinical nutrition.

[15]  A. Bongiovanni,et al.  The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. , 1967, Pediatrics.

[16]  F. Conte,et al.  Serum growth hormone response to insulin-induced hypoglycemia in disorders of growth , 1965 .

[17]  D. Schalch,et al.  A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma , 1964, Nature.